Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036690 (
sepsis
)
59,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Toll-like receptor (TLR) signaling is tightly controlled to protect hosts from microorganisms while simultaneously preventing uncontrolled immune responses. Tumor necrosis factor receptor-associated factor 6 (TRAF6) is a critical mediator of TLR signaling, but the precise mechanism of how TRAF6 protein stability is strictly controlled still remains obscure. We show that myeloid-specific deletion of
inositol polyphosphate multikinase
(
IPMK
), which has both inositol polyphosphate kinase activities and noncatalytic signaling functions, protects mice against polymicrobial
sepsis
and lipopolysaccharide-induced systemic inflammation.
IPMK
depletion in macrophages results in decreased levels of TRAF6 protein, thereby dampening TLR-induced signaling and proinflammatory cytokine production. Mechanistically, the regulatory role of
IPMK
is independent of its catalytic function, instead reflecting its direct binding to TRAF6. This interaction stabilizes TRAF6 by blocking its K48-linked ubiquitination and subsequent degradation by the proteasome. Thus, these findings identify
IPMK
as a key determinant of TRAF6 stability and elucidate the physiological function of
IPMK
in TLR-induced innate immunity.
...
PMID:Inositol polyphosphate multikinase promotes Toll-like receptor-induced inflammation by stabilizing TRAF6. 2843 46